Enjuvia FDA Approval History
FDA Approved: Yes (Discontinued) (First approved May 10, 2004)
Brand name: Enjuvia
Generic name: synthetic conjugated estrogens, B
Dosage form: Tablets
Company: Duramed Pharmaceuticals
Treatment for: Postmenopausal Symptoms, Atrophic Vaginitis
Marketing Status: Discontinued
Enjuvia (synthetic conjugated estrogens, B) is a synthetic conjugated estrogen product indicated for the treatment of menopausal vasomotor symptoms and for the treatment of vaginal dryness and atrophy.
Development timeline for Enjuvia
| Date | Article |
|---|---|
| Apr 30, 2007 | Approval Duramed's Enjuvia (Synthetic Conjugated Estrogens, B) TabletsReceives Two New FDA Approvals |
| May 10, 2004 | Approval Enjuvia Duramed Pharmaceuticals - Treatment for Menopausal Vasomotor Symptoms |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
